REVA to Hold Company Update Call
March 31, 2014 19:40 ET
|
REVA Medical Inc
SAN DIEGO, March 31, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold a conference call to discuss the Company's decision to fast-track the development of its...
REVA to Focus on Breakthrough Scaffold: Fantom
March 27, 2014 02:17 ET
|
REVA Medical Inc
Highlights:
Fantom™ scaffold family, a significant product advance over ReZolve® technology
Fast-track development of Fantom "thin-strut" fully bioresorbable...
REVA to Hold Briefing Call on Financial Results for 2013 and Present at Cowen Health Care Conference
February 23, 2014 18:04 ET
|
REVA Medical Inc
SAN DIEGO, Feb. 23, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold a conference call to discuss the Company's financial results through December 31, 2013,...
REVA to Present at CRT 2014 Conference
February 23, 2014 17:34 ET
|
REVA Medical Inc
SAN DIEGO, Feb. 23, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that Dr. Alexandre Abizaid, co-principal investigator for REVA's RESTORE II...
REVA Hires Vice President, General Counsel
February 10, 2014 20:17 ET
|
REVA Medical Inc
SAN DIEGO, Feb. 10, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that David M. Eisler, Esq., has joined the Company's executive team as Vice...
REVA Announces Completion of ReZolve2 Clinical Enrollment and Upcoming Presentation at J.P. Morgan Conference
January 13, 2014 18:23 ET
|
REVA Medical Inc
SAN DIEGO, Jan. 13, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that it has completed enrollment in the clinical trial of the ReZolve2...
REVA to Hold Briefing Call on Q3 2013 Financial Results
November 05, 2013 23:57 ET
|
REVA Medical Inc
SAN DIEGO, Nov. 5, 2013 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold a conference call to discuss the Company's financial results through September 30, 2013 and...
REVA Announces Transmission of ReZolve2 Implant and Pilot Trial Update at TCT 2013
October 30, 2013 03:02 ET
|
REVA Medical Inc
SAN DIEGO, Oct. 30, 2013 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") announces that in conjunction with Transcatheter Cardiovascular Therapeutics 2013 ("TCT"), which is...
REVA Announces First Clinical Results From ReZolve2 Trial
October 28, 2013 02:16 ET
|
REVA Medical Inc
SAN DIEGO, Oct. 28, 2013 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") announced initial clinical results from patients treated with its ReZolve2 sirolimus-eluting...
REVA Medical to Hold Briefing Call on Q2 2013 Financial Results
August 06, 2013 19:14 ET
|
REVA Medical Inc
SAN DIEGO, Aug. 6, 2013 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold a conference call to discuss the Company's financial results through June 30, 2013 and its...